Table 6.
The isoflavone intakes in groups of individuals with ulcerative colitis declaring either lack or presence of fecal pus.
| Intake of Isoflavones | Individuals Declaring Lack of Fecal Pus (n = 53) | Individuals Declaring Fecal Pus (n = 3) | p-Value ** | ||
|---|---|---|---|---|---|
| Mean ± SD | Median (min–max) |
Mean ± SD | Median (min–max) |
||
| Daidzein (µg) | 138.3 ± 155.0 | 103.3 (3.3–977.7) * | 255.1 ± 84.8 | 206.7 (205.7–353.0) * |
0.049 |
| Genistein (µg) | 178.7 ± 223.0 | 135.0 (2.3–1428.3) * | 156.3 ± 86.4 | 126.7 (88.7–253.7) |
0.771 |
| Glicytein (µg) | 2.0 ± 9.0 | 0.0 (0.0–56.0) * | 0.0 ± 0.0 | 0.0 (0.0–0.0) * |
0.654 |
| Total isoflavones (µg) | 319.0 ± 289.9 | 256.0 (18.0–1574.0) * | 411.4 ± 68.2 | 441.7 (333.3–459.3) |
0.167 |
* nonparametric distribution (verified using Shapiro–Wilk test; p ≤ 0.05); ** compared using Mann–Whitney U test (due to nonparametric distribution).